Literature DB >> 3664254

Renal impairment following biliary tract surgery.

J N Thompson1, W H Edwards, C G Winearls, J I Blenkharn, I S Benjamin, L H Blumgart.   

Abstract

Postoperative mortality has been directly attributed to renal failure in approximately 5 per cent of patients after surgery for obstructive jaundice. An analysis of 334 patients undergoing biliary tract surgery was undertaken to identify the perioperative factors associated with the development of renal impairment, and to estimate the contribution of renal failure to mortality. Thirty-eight patients (11 per cent) developed postoperative renal impairment (a two-fold increase in serum creatinine postoperatively or a rise of greater than 100 mumol/l). Ninety-three factors were examined in these and 196 control patients. Stepwise logistic regression analysis identified only three factors which were significantly associated with renal impairment: postoperative sepsis (P less than 0.0005), pre-operative serum bilirubin (P less than 0.0005), and pre-operative urea (P less than 0.05). Renal impairment developed at a median 4 days after surgery and was associated with a median of two additional major postoperative complications, particularly sepsis and haemorrhage, for which 17 patients underwent reoperation. Twenty-eight (74 per cent) of the patients with renal impairment died in hospital, but in only one case was the cause of death directly related to renal failure. Twenty patients received specific therapy for renal failure, but only one of these survived. Pre-operative obstructive jaundice and postoperative infection are the major factors associated with renal impairment after biliary tract surgery. Renal impairment appears to be related to postoperative complications rather than directly to the surgical procedure itself. The development of postoperative renal impairment predicts a low chance of survival but appears to be an indicator, rather than a direct cause of a poor prognosis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3664254     DOI: 10.1002/bjs.1800740932

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  8 in total

1.  Factors affecting morbidity and mortality in biliary tract surgery.

Authors:  C H Su; F K P'eng; W Y Lui
Journal:  World J Surg       Date:  1992 May-Jun       Impact factor: 3.352

2.  Decreased hepatic peroxisome proliferator-activated receptor-γ contributes to increased sensitivity to endotoxin in obstructive jaundice.

Authors:  Xin Lv; Jian-Gang Song; Hong-Hai Li; Jun-Ping Ao; Ping Zhang; Ye-Sheng Li; Shao-Li Song; Xiang-Rui Wang
Journal:  World J Gastroenterol       Date:  2011-12-28       Impact factor: 5.742

3.  Bacterial translocation and intestinal morphological findings in jaundiced rats.

Authors:  Pierpaolo Sileri; Sergio Morini; Giuseppe S Sica; Stefano Schena; Cristiana Rastellini; Achille L Gaspari; Enrico Benedetti; Luca Cicalese
Journal:  Dig Dis Sci       Date:  2002-04       Impact factor: 3.199

Review 4.  Acute renal failure in general surgery.

Authors:  M Slapak
Journal:  J R Soc Med       Date:  1996       Impact factor: 5.344

5.  Improvements in survival by aggressive resections of hilar cholangiocarcinoma.

Authors:  H U Baer; S C Stain; A R Dennison; B Eggers; L H Blumgart
Journal:  Ann Surg       Date:  1993-01       Impact factor: 12.969

6.  LPS-binding protein mediates LPS-induced liver injury and mortality in the setting of biliary obstruction.

Authors:  Rebecca M Minter; Xiaoming Bi; Gal Ben-Josef; Tianyi Wang; Bin Hu; Saman Arbabi; Mark R Hemmila; Stewart C Wang; Daniel G Remick; Grace L Su
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-10-23       Impact factor: 4.052

7.  Early mortality in 100 consecutive liver resections in 96 patients with benign and malignant liver tumours.

Authors:  N A Habib
Journal:  Ann R Coll Surg Engl       Date:  1995-03       Impact factor: 1.891

8.  Protective effects of intravenous anesthetics on kidney tissue in obstructive jaundice.

Authors:  Sinan Hatipoglu; Huseyin Yildiz; Ertan Bulbuloglu; Ismail Coskuner; Ergul Belge Kurutas; Filiz Hatipoglu; Harun Ciralik; Mehmet Sait Berhuni
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.